CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Nipro Corp is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Nipro Corp
3-26, Senriokashin-machi
Phone: +81 663106907p:+81 663106907 SETTSU-SHI, OSK  566-8510  Japan Ticker: 80868086
Business Summary
Nipro Corp is a Japan-based company mainly engaged in the medical, pharmaceutical, and pharma packaging businesses. It has three segments. The Medical segment consists of the domestic business division and the international business division. The domestic business division sells medical devices related to injections and infusions, artificial organs, high-performance medicines, and dialysis. The international business division, centered on the head office, has medical device manufacturing and sales bases overseas for regional expansion, selling medical devices related to injections and infusions, artificial organs, and diabetes. The Pharmaceutical segment sells pharmaceuticals related to kit preparation containers on a contract basis from pharmaceutical companies. The Pharma Packaging segment sells medical glass products such as glass tubes and ampoules, thermos flasks, and kit preparation containers in Japan.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/20253/31/2025Yes---Yes

Industries
SIC Code Description
3841 Surgical and medical instruments and apparatus
2834 Pharmaceutical preparations
3221 Glass containers
6519 Lessors of real property, not elsewhere classified
3842 Orthopedic, prosthetic, and surgical appliances and supplies
5047 Medical, dental, and hospital equipment and supplies

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, Representative Director YoshihikoSano 79 6/26/2025 4/1/2001
President, Representative Director TsuyoshiYamazaki 56 6/26/2025 6/1/2009
Chief Financial Officer, Senior Managing Director TakehitoYogo 56 6/1/2025 6/1/2018
12 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Goodman Co., Ltd. 5F KDX Nagoya Sakae Building Nagoya ACH Japan
NIPRO Technical Solutions, Inc. 3110 N Oakland Mesa AZ United States
Nipro Medical Corporation 3150 NW 107th Avenue Doral FL United States
3 additional Subsidiary records available in full report.

Business Names
Business Name
8086
Goodman Co., Ltd.
Goodman USA, Inc.
21 additional Business Names available in full report.

General Information
Number of Employees: 39,168 (As of 3/31/2025)
Outstanding Shares: 163,095,654 (As of 6/30/2025)
Shareholders: 53,685
Stock Exchange: TYO
Fax Number: +81 663717422
Email Address: customercare@niprodiagnostics.com


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, September 9, 2025
Register now for our FAST Rating webinar on September 10 at 2:00 PM ET!